Christopher V. SmithKline: Impact On Pharma — And Beyond

In an article on the U.S. Supreme Court’s June 18, 2012 decision in Christopher v. SmithKline Beecham Corp, Littler’s Lee Schreter, Richard Black & Libby Henninger discuss the implications of the ruling that pharmaceutical sales representatives were properly classified as exempt outside sales employees.

The authors note that not only is the decision a significant victory for the pharmaceutical industry and employers generally, but it will have a far-reaching impact on federal agencies by limiting their ability to effectuate new interpretations of federal statutes and regulations via amicus briefs. They also discuss the impact on the standard courts should apply in determining the applicability of Fair Labor Standards Act exemptions.

View Article